Skip to main content
ALK-Abelló logo

ALK-Abelló — Investor Relations & Filings

Ticker · ALK ISIN · DK0061802139 LEI · 529900SGCREUZCZ7P020 CO Manufacturing
Open in API
Filings indexed 1,210 across all filing types
Latest filing 2020-08-12 Interim / Quarterly Rep…
Country DK Denmark
Listing CO ALK

About ALK-Abelló

https://www.alk.net

ALK-Abelló is a global, research-driven pharmaceutical company specializing in the prevention, diagnosis, and treatment of allergies. The company is a world leader in allergy immunotherapy (AIT), also known as allergy vaccination, which is a disease-modifying treatment that targets the underlying cause of the allergy rather than just the symptoms. Its portfolio includes a range of allergy treatments and services, with products such as injections, sublingual tablets, and emergency treatments for severe allergic reactions like anaphylaxis. With over a century of experience, ALK-Abelló focuses on developing pharmaceutical products to improve the quality of life for people with allergies globally.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2020
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Six-month interim report (Q2) 2020' and contains comprehensive financial statements, including income statements, balance sheets, and cash flow data for the H1 and Q2 periods. It provides a detailed management discussion and analysis of business performance, COVID-19 impacts, and financial outlook. It is not a mere announcement or certification, but the substantive interim financial report itself. H1 2020
2020-08-12 English
Six-month interim report (Q2) 2020
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Six-month interim report (Q2) 2020' and contains substantive financial data, including revenue, EBITDA, and free cash flow figures for the period. While it mentions a conference call and provides a link to a file, the document itself provides the actual financial results and management commentary, distinguishing it from a mere announcement or certification. Therefore, it is classified as an Interim/Quarterly Report. H1 2020
2020-08-12 English
Earnings Release 2020
Earnings Release Classification · 100% confidence The document is explicitly titled 'Six-month interim report (Q2) 2020' and contains detailed financial highlights (revenue, operating profit, cash flow) for the first six months of the year, along with an updated financial outlook. This content structure perfectly matches the definition of an Interim/Quarterly Report. Although it mentions a conference call and an attachment, the core document provided is the comprehensive report itself, not just the announcement of its publication. Therefore, the classification is 'Interim / Quarterly Report' (IR). H1 2020
2020-08-12 English
Interim / Quarterly Report 2020
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Six-month interim report (Q2) 2020' and contains comprehensive financial statements, including income statements, balance sheets, and cash flow data for the H1 and Q2 periods. It provides a detailed management discussion and analysis of business performance, COVID-19 impacts, and financial outlook. It is not a mere announcement or certification, but the substantive interim financial report itself. H1 2020
2020-08-12 English
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
Director's Dealing Classification · 100% confidence The document is a formal notification of transactions made by a person with managerial responsibilities (the CEO, Carsten Hellmann) in ALK-Abelló A/S shares and related financial instruments. It follows the standard regulatory format for reporting insider dealings (Director's Dealing), including details on the nature of the transaction, the financial instrument, the price, and the date. This fits the definition of a Director's Dealing (DIRS) filing.
2020-05-20 Danish
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
Director's Dealing Classification · 100% confidence The document is a formal notification of transactions made by a person with managerial responsibilities (the CEO, Carsten Hellmann) regarding ALK-Abelló A/S shares and stock options. This is a standard regulatory disclosure for insider trading/director dealings, which fits the 'Director's Dealing' (DIRS) category perfectly.
2020-05-20 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.